在HCC细胞进展中NLRP3炎症酶激活的作用
Bingling Dai1,2, Hanbing Cao1,2, Yu Hu1,2
1School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, PR China.
Heliyon
|September 8, 2023
概括
激活NLRP3炎症酶,这是癌症进展的关键组成部分,抑制肝细胞癌细胞的增殖和迁移. 这一发现表明,准NLRP3炎症酶可能为肝癌提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症相关死亡的主要原因.
- 在HCC进展中NLRP3炎症酶的作用尚未完全理解.
- 在一些HCC细胞中观察到低NLRP3炎症酶表达.
研究的目的:
- 为了研究HCC中NLRP3炎症酶激活的机制.
- 为了确定NLRP3炎症酶激活对HCC细胞行为的影响.
主要方法:
- 使用LPS+ATP通过核因子kappa B通路激活NLRP3炎症酶.
- 使用Edu染色,细胞周期分析,Annexin V/PI染色和伤口愈合试验评估HCC细胞增殖,细胞循环,细胞亡和迁移.
- 通过西部涂抹和免疫光染色来验证NLRP3炎症酶激活.
主要成果:
- 通过西部涂抹和免疫光检测证实了NLRP3炎症酶激活.
- 激活的NLRP3炎症酶抑制了HCC细胞的增殖和迁移 (Bel-7402和SMMC-7721).
- 观察到G1阶段的细胞周期停止,对细胞亡没有显著影响.
结论:
- NLRP3炎症酶激活在HCC细胞中显示出抗瘤作用.
- 准NLRP3炎症酶组是肝细胞癌的潜在治疗策略.
更多相关视频
09:04Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
21.0K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.4K
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
